Professor Zofia Miedzybrodzka
MB ChB, PhD, FRCP Edin, FRCOG
Personal Chair (Clinical)
Zosia Miedzybrodzka is Professor of Medical Genetics at the University of Aberdeen. She is also honorary consultant clinical geneticist and Service Clinical Director of Genetics for NHS Grampian (comprising Clinical Services and diagnostic DNA and cytogenetics laboratories), and co-director of the University of Aberdeen Centre for Genome-enabled Biology and Medicine.
Her areas of work place her on the interface between Clinical Practice and Research. her interests lie in the application of genetic techology to medicine. Current projects focus on genetic biomarkers for treatment response in gastro-oesophageal cancer, genetics and care in Huntington's disease, improving delivery of familial hypercholesterolaemia services. She is lead for NHS implementation within the Scottish Genomes Project. Currently she is Chair of the Scottish Clinical Genetics Forum and specialty adviser to the Chief Medical Officer for clinical genetics.
Page 1 of 14 Results 1 to 10 of 138
The known burden of Huntington disease in the north of Scotland: prevalence of manifest and identified pre-symptomatic gene expansion carriers in the molecular eraJournal of Neurology, vol. 268, pp. 4170-4177Contributions to Journals: Articles
Continuing the sequence?: Towards an Economic Evaluation of Whole Genome Sequencing for the Diagnosis of Rare Diseases in ScotlandJournal of Community GeneticsContributions to Journals: Articles
Creation and Worldwide Utilisation of New COVID-19 Online Information Hub for Genetics Health Professionals, Patients and FamiliesFrontiers in Genetics, vol. 12, 621683Contributions to Journals: Articles
Optimized EGFR Blockade Strategies in EGFR Addicted Gastroesophageal AdenocarcinomasClinical Cancer Research, vol. 27, no. 11, pp. 3126-3140Contributions to Journals: Articles
A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriersNature Communications, vol. 12, no. 1, 1078Contributions to Journals: Articles
Interactions between anti-EGFR therapies and cytotoxic chemotherapy in oesophageal squamous cell carcinoma: why clinical trials might have failed and how they could succeedCancer Chemotherapy and Pharmacology, vol. 87, pp. 361–377Contributions to Journals: Articles
Genetic predisposition to hypertension is associated with preeclampsia in European and Central Asian womenNature Communications, vol. 11, no. 1, 5976Contributions to Journals: Articles
Young-onset colorectal cancer in the North East of Scotland: survival, clinico- pathological features and geneticsBMC Cancer, vol. 20, 108Contributions to Journals: Articles
Genetics professionals’ experiences of facilitating parent/child communication through the genetic clinicJournal of genetic counseling, vol. 29, no. 1, pp. 44-55Contributions to Journals: Articles
Letter in Response to Tibben et al., Risk Assessment for Huntington's Disease for (Future) Offspring Requires Offering Preconceptional CAG Analysis to Both PartnersJournal of Huntington's disease, vol. 8, no. 3, pp. 357-359Contributions to Journals: Letters